Characteristics of Transdermal Patches

Similar documents
Characteristics of Transdermal Patches

Inhaled Corticosteroid Dose Comparison in Asthma

Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes

VTE Prevention After Hip or Knee Replacement

Curraheen, Co.Cork. Disclaimer: The information contained within this policy is accurate and up-to-date at date of approval.

Drugs with Handling Concerns Due to Reproductive Risk

TRANSDERMAL INNOVATION

Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG

Chantix (Varenicline) and Risk of Cardiovascular Events

Transdermal Adhesives

Shingles Vaccine: FAQs

Sepsis and Septic Shock: New Definitions for Adults

Compounding KI for Radiation Exposure

Medications for Alzheimer s disease: are they right for you?

FDA Perspectives on Product Quality of Transdermal Drug Delivery Systems

INFORMATION FOR THE CONSUMER

Menopausal Symptoms. Hormone Therapy Products Available in Canada for the Treatment of. Physician Desk Reference - 3rd Edition

Naloxone Rescue Therapy for Opioid Overdose (16-242)

Patient Information. Sancuso [san-koo-so] (granisetron transdermal system)

Drug Information Sheet("Kusuri-no-Shiori")

Contraception for Women With Chronic Medical Conditions

Antihypertensive Combinations

Aspirin for the Prevention of Cardiovascular Disease

Shingles Vaccine: FAQs

Medication Guide Fentanyl Transdermal System, CII (fĕn tə-nĭl) Fentanyl transdermal system is:

KEEP IT SIMPLE WITH SANCUSO. Prevent chemotherapy induced nausea and vomiting with Sancuso Patch for up to 5 full days3

Package leaflet: Information for the user

Drugs for Parkinson s Disease

CONSUMER MEDICINE INFORMATION

Concepts for the talk. Poisoning by Topical Medications The Toxicology of Transdermal Drug Delivery. Early patches. The transdermal patch

Ontario Drug Benefit Formulary/Comparative Drug Index

Prescribing Examples: Basics

Medication Guide Fentanyl transdermal system, CII Rx Only Fentanyl transdermal system is: A strong prescription pain medicine that contains an opioid

Updated Guidelines for Antiretroviral Agents in Pediatric Patients: Focus on Adverse Events

PATIENT INFORMATION NEUPRO [NU pro] (rotigotine transdermal system)

Hormone Products for Postmenopausal Use in the United States and Canada

Why do I need to use Fentanyl Patches?

Equianalgesic Dosing of Opioids for Pain Management

Canadian Expert Drug Advisory Committee Final Recommendation Plain Language Version

IMPORTANT POINTS ABOUT MEDICATIONS

Nitro-Dur 0.2 mg/h, 0.4 mg/h, 0.6 mg/h Transdermal Patch Glyceryl trinitrate

Pharmacokinetic overview of Ortho Evra /Evra

A Personalized Approach for A1C Goals

Transiderm-Nitro 5 milligrams/24 hours, Transiderm-Nitro10 milligrams/24 hours and Transiderm-Nitro15 milligrams/24 hours Transdermal patch

DUTRAN Transdermal Drug Delivery System

This letter is to notify you of recent changes to the TAMIFLU product monograph. Please note, additions/changes have been highlighted in yellow.

PATIENT INFORMATION NEUPRO [NU pro] (rotigotine transdermal system)

Formulation Factors. Other Considerations. Transdermal Drug Delivery

Patch adhesion and local tolerability of Transdermal Delivery Systems Requirements according to the new draft EMA Guidelines

Thank you very much for agreeing to participate in the Ontario Sleep Health Study

PART III: CONSUMER INFORMATION ABOUT THIS MEDICATION. APO-FENTANYL MATRIX fentanyl transdermal system

Ottawa Public Health Pam Oickle Sarah Archer

Coversheet for Network Site Specific Group Agreed Documentation

HTN: 80 mg once daily 23,f 80 mg once daily 23,f Hypertension 40, 80 mg $82.66 (80 mg once daily) HTN: 8-32 mg daily in one or two divided doses 1

Long Term Care Formulary HCD - 08

Thank you very much for agreeing to participate in the Ontario Sleep and Brain Health Study

Drivers have GPS. Dialysis Patients have. Making possible personal.

Where do you get most of your information about medications?

An advanced hydrocolloid dressing for moderately exuding wounds

Duragesic patch. Duragesic patch (fentanyl patch) Description

Disclosure. Being a medical caregiver means putting your self in suffering s way. Prescribing opioids The pain that won t go away

gentle catheter clip USER GUIDE optimum medical support optimummedical independence with confidence

Status Update on the National Cardiovascular Prevention Guidelines - JNC 8, ATP 4, and Obesity 2

Cannabis and HIV/AIDS:

Medications. Managing and Administering Medication

SAFE HANDLING OF VACCINES

1160 Park Avenue 31 River Road New York, NY Greenwich, CT Tel Tel

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

Acute Migraine Treatment in Adults

Medication Administration. By: Carolyn McCune RN, BSN, MSN, CRNP

4 INSTRUCTOR GUIDELINES

Transdermal Drug Delivery Free Ce

1. INDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY UNDERTAKING Trade name

Contact Allergy Testing (Patch Testing) Information for parents and carers of children up to 12 years of age

Fighting the Good Fight: How to Convert Opioids Just Right!

Nephrostomy Tube Care

1160 Park Avenue 31 River Road New York, NY Greenwich, CT Tel Tel POST OPERATIVE SHOULDER INSTRUCTIONS

Decreasing the Harms from Prescription Drug Misuse: A Case for Pharmacists and Prescription Monitoring Programs

UPDATE AU Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective May 31, 2013 SUMMARY OF CHANGES

This letter is to notify you of recent changes to the PULMOZYME product monograph. Please note, additions/changes have been highlighted in yellow.

Home Care for Your Nephrostomy Catheter - The James

Comparison of Atypical Antipsychotics

What is a Leaderflex catheter?

School of Pharmacy Faculty of Medicine The Chinese University of Hong Kong. Transdermal Drug Delivery System

Sorafenib (Nexavar ) ( sor-af-e-nib )

Q&A: Opioid Prescribing for Chronic Non-Malignant Pain

Stereotactic core biopsy of the breast

Salford Audiology Services

Information for patients preparing for recovery at home. You have had an anesthetic or narcotic medicine.

Technique Guide. SynPOR HD Ocular Spheres. For augmentation or reconstruction.

Pharmacy Medical Necessity Guidelines: Opioid Analgesics

Date Printed: 04/24/2008 Date Updated: 01/29/2006 Version 1.4

Flu Vaccines for

Session VI. Presenter Disclosure Information. Learning Objectives for Session VI. Prescribing Information. Prescribers Must Be Knowledgeable

Ontario Drug Benefit Formulary/Comparative Drug Index

Electrocardiography for Healthcare Professionals

Berkshire West Area Prescribing Committee Guidance

Changing Your Two-Piece Disposable Urostomy Appliance

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. N FENTANYL PATCH Fentanyl Transdermal Patches (Matrix)

Naloxone for Opioid Overdose (FAQs)

Transcription:

This Clinical Resource gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER July 2017 ~ Resource #330733 Characteristics of Transdermal Patches Transdermal patches offer an attractive route of administration for patients who are unable to swallow oral medications and to avoid the need for pain or risks associated with intravenous administration. Patches may also allow for less frequent dosing and improved adherence. Refer to the Cheat Sheet for Dos and Don ts With Patches, for things to consider that may be similar among most available patches, including application, exposure to heat, disposal, and to help determine if it is safe or appropriate to cut a patch. Use the chart below to determine how to address common questions associated with individual patches, including exposure to water and what to do if patches fall off, as these may be different from patch to patch. For guidance about when patches can be cut, see our Cheat Sheet for Dos and Don ts With Patches. Please note that this table provides information about many brand name and generic patches, yet there may be other generics patches available that are not listed. Information may be different for generic products. Products listed on the chart are representative and may not be all-inclusive. Buprenorphine (BuTrans) Beige, rectangular or square (varies with dose), If patch becomes loose, may tape edges with first-aid tape, being sure not to cover any printing on the patch. If the patch comes off, replace with a new patch, o Applying a new patch, starts a new dosing interval. o If two patches are worn at the same time and one comes off, remove the other patch; apply two new patches, Estradiol (Climara) Translucent, oval Estradot Transparent, rectangular If patch comes off, apply a new patch, rotating sites and follow

(Clinical Resource #330733: Page 2 of 6) Continued Estradiol, continued Other brands: same as Climara Estradot, Oesclim, Sandoz Estradiol Derm Oesclim Beige, rectangular, foam-like Sandoz Estradiol Derm Transparent, oval Estradot, Oesclim, and Sandoz Estradiol Derm If patch becomes loose or falls off, the same patch may be reapplied, Levonorgestrel (Climara Pro) Norethindrone (Estalis) Translucent, oval If patch becomes loose or falls off, the same patch may be reapplied, Round If patch becomes loose or falls off, the same patch may be reapplied, Norelgestromin (Evra) Beige, plastic Do not use tapes or wraps to keep the patch in place. If patch becomes loose or falls off for up to 24 hours, attempt to reapply it, and follow same dosing schedule. o No backup contraception 2

(Clinical Resource #330733: Page 3 of 6) Continue Norelgestromin (Evra), continued needed. If unable to reapply or the patch falls off for >24 hours or an unknown amount of time, apply a new patch, o Backup contraception needed for the first week of the new cycle. o New patch begins a new fourweek cycle. Fentanyl (Duragesic) Other brands: same as Duragesic Apo-Fentanyl, Co Fentanyl, Fentanyl Patch (Pro Doc Limitee), Mylan- Fentanyl Patch, pms-fentanyl MTX, Ran-Fentanyl Patch, Sandoz Fentanyl Patch, Teva- Fentanyl Rectangular, thin, tape-like Apo-Fentanyl Tan, rectangular, May use first-aid tape on the edges, or cover with transparent adhesive dressing if patch becomes loose. If patch falls off, apply a new patch, o Applying a new patch, starts a new dosing interval. Lidocaine/Prilocaine (EMLA) Absorbant cellulose disc Tan Patches should only be worn for a maximum of five hours; therefore it is unlikely that patches will become loose or fall off. Patches should only be worn for a maximum of five hours; therefore water exposure should not be an issue.

(Clinical Resource #330733: Page 4 of 6) Nicotine (NicoDerm, Habitrol) same for both products NicoDerm: 3 Drug reservoir in a matrix Habitrol: 5 NicoDerm Transparent, rectangular 3 Habitrol Square May use medical adhesive tape, if patch becomes loose (NicoDerm). 1 If patch falls off, apply new patch, a,1 o Continue with same dosing schedule (Habitrol). 1 Nitroglycerin (Minitran) Other brands: same as Minitran Mylan-Nitro, Nitro- Dur, Transderm- Nitro, Trinipatch Controlledrelease, remainder serves as reservoir, but is not delivered Transderm Nitro: Reservoir Trinipatch: Nitro-Dur: 4 Clear, oval, tape-like Mylan-Nitro Clear, oblong, tape-like, Nitro-Dur Tan, round Transderm-Nitro Tan, rectangular If patch falls off, apply new patch, rotating sites, and follow same dosing schedule. Nitro-Dur: If patch falls off, clean the skin, apply new patch, 4 Nitro-Dur: Showering is safe to do while wearing the patch. Oxybutynin (Oxytrol) Translucent, rectangular, If patch comes completely off, may attempt to reapply.

(Clinical Resource #330733: Page 5 of 6) Rivastigmine (Exelon) Opaque, round, plastic, imprinted with drug name,, and the following letters: AMCX (5 mg) BHDI (10 mg) CNFU (15 mg) If the patch comes off, apply new Rotigotine (Neupro) Beige, square, tape-like, an identification mark If patch comes off, apply a new Scopolamine* (Transderm-V) *licensed natural health product Reservoir 6 Tan, disc 7 If patch comes off, apply a new patch behind the other ear. 7 7 Testosterone (Androderm) Reservoir N/A from the manufacturer If patch comes off, do not replace it until the nighttime application, It is not known how long to delay showering or swimming after patch application. It is not necessary to remove while bathing. a. Information from Canadian product monograph specified: BuTrans (August 2016); Climara (February 2016); Estradot (July 2014); Oesclim (February 2017); Sandoz Estradiol Derm (March 2009); Climara Pro (March 2016); Estalis (July 2014); Evra (February 2017); Duragesic (April 2017); Apo-Fentanyl (April 2016); Co Fentanyl (November 2014); Fentanyl Patch (Pro Doc Limitee, May 2016); Mylan-Fentanyl Patch (February 2017); pms-fentanyl MTX (July 2016); Ran-Fentanyl Patch (August 2016); Sandoz Fentanyl Patch (January 2016); Teva-Fentanyl (February

(Clinical Resource #330733: Page 6 of 6) 2016); EMLA Patch (April 2016); Habitrol (March 2005); Minitran (August 2015); Mylan-Nitro Patch (March 2016); Nitro-Dur (February 2015); Transderm- Nitro (August 2015); Trinipatch (January 2009); Oxytrol (February 2017); Exelon Patch (July 2016); Neupro (September 2014); Androderm (November 2016).

(Clinical Resource #330733: Page 7 of 6) Users of this resource are cautioned to use their own professional judgment and consult any other necessary or appropriate sources prior to making clinical judgments based on the content of this document. Our editors have researched the information with input from experts, government agencies, and national organizations. Information and internet links in this article were current as of the date of publication. Project Leader in preparation of this clinical resource (330733): Beth Bryant, Pharm.D., BCPS, Assistant Editor References 1. NicoDerm Canada. About NicoDerm. https://www.nicoderm.ca/about-nicoderm. (Accessed June 12, 2017). 2. Personal communication (verbal). Maurice. Medical information. Janssen Inc. Toronto, Ontario M3C 1L9. June 12, 2017. 3. Canoe Health. NicoDerm. http://chealth.canoe.com/drug/getdrug/nicoderm. (Accessed June 12, 2017). 4. Personal communication (verbal). Cindy. Medical information. Merck Canada, Inc. Kirkland, QC H9H 4M7. June 12, 2017. 5. Personal communication (verbal). Charlie. Medical information. GlaxoSmithKline Canada. Mississauga, Ontario L5N 6L4. June 13, 2017. 6. Personal communication (verbal). Youcef. Medical Information. Sandoz Canada. A division of Novartis. Boucherville, QC J4B 1E6. June 21, 2017. 7. Information for the consumer for Transderm-V. Sandoz Canada. Boucherville, QC J4B 7K8. February 2017. Cite this document as follows: Clinical Resource, Characteristics of Transdermal Patches. Pharmacist s Letter/Prescriber s Letter. July 2017. Evidence and Recommendations You Can Trust 3120 West March Lane, Stockton, CA 95219 ~ TEL (209) 472-2240 ~ FAX (209) 472-2249 Copyright 2017 by Therapeutic Research Center Subscribers to the Letter can get clinical resources, like this one, on any topic covered in any issue by going to PharmacistsLetter.com, PrescribersLetter.com, PharmacyTechniciansLetter.com, or NursesLetter.com